abstract |
Compounds and methods are provided for treating diseases or disorders affected by the activity or expression of genes/proteins associated with human GH, GHR, STAT5, SOCS, IGF-1, insulin. Also provided are monoclonal antibodies for use in the treatment of diseases or disorders associated with growth hormone and growth hormone receptor activity. |